TP53 and glioblastoma: Similarly, miR-222, the only differentially expressed miRNA identified as a predictor of LTS, has been previously documented in the literature [46] as predictor of GBM prognosis due to its role as a regulator of the PUMA [47], a P53 mediated regulator of apoptosis.